Quantbot Technologies LP Kinnate Biopharma Inc. Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$1.38 - $3.31 $552 - $1,324	-400 Reduced 12.9%	2,700 $3,000
Q2 2023 Aug 08, 2023	BUY	$2.33 - $6.84 $7,223 - $21,204	3,100 New	3,100 $9,000
Q2 2022 Aug 09, 2022	SELL	$7.43 - $13.0 $17,832 - $31,200	-2,400 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.73 - $17.99 $18,552 - $43,175	2,400 New	2,400 $27,000

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.